{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":13,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":13,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6ac19511148b","filters":{"venue":"Section 4: Clinical pharmacy services"}},"results":[{"id":"W2944589946","doi":"10.1136/ejhpharm-2019-eahpconf.403","title":"4CPS-254 Biosimilar rituximab – a year beyond","year":2019,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Kidney Foundation of Canada","keywords":"Biosimilar; Rituximab; Medicine; Discontinuation; Rheumatoid arthritis; Pharmacy; Retrospective cohort study; Internal medicine; Oncology; Lymphoma; Family medicine","authors":[{"name":"Mafalda Sá Pereira","is_ca":false},{"name":"Giovanna de Oliveira Sá Costa","is_ca":false},{"name":"S Domingos-Camões","is_ca":false},{"name":"A Alcobia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03496363757777717,"gpt":0.3810492240157845,"spread":0.3460855864380074,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001146247,0.000260568,0.0005460038,0.000101428,0.0001504919,0.00004321252,0.0003992041,0.0004123363,0.01152825],"category_scores_gemma":[0.00005099558,0.000210282,0.000352093,0.0003109396,0.0001806064,0.0002066918,0.0001737478,0.0008703194,0.004863056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002523202,"about_ca_system_score_gemma":0.00004630303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001040915,"about_ca_topic_score_gemma":0.00003339842,"domain_scores_codex":[0.9975029,0.0005559264,0.0007486133,0.0006549348,0.00008267353,0.0004550002],"domain_scores_gemma":[0.9986966,0.0004415966,0.0002232749,0.0004157591,0.000129863,0.00009291705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004905067,0.00537224,0.5117972,0.00090528,0.002874013,0.00002995037,0.0004405288,0.00001170162,0.3026558,0.002126279,0.08273812,0.08614381],"study_design_scores_gemma":[0.00615474,0.0003460073,0.01255129,0.00004184309,0.0001842817,0.00002101123,0.0001743546,0.0001558138,0.02220953,0.0007888894,0.9569972,0.0003750001],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9538316,0.002342569,0.00007077746,0.006162045,0.01508047,0.0006314881,0.00009755226,0.0003756444,0.02140792],"genre_scores_gemma":[0.9788494,0.0006247693,0.0007904989,0.01205272,0.0006561105,0.00001157637,0.00006177589,0.00003631345,0.006916836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8742591,"threshold_uncertainty_score":0.9959118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393026380","doi":"10.1136/ejhpharm-2024-eahp.245","title":"4CPS-141 Real-life impact of including montelukast as premedication on the incidence of infusion-related reactions to isatuximab and description of risk factors","year":2024,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; University of Waterloo","keywords":"Discontinuation; Tolerability; Medicine; Regimen; Placebo; Premedication; Odds ratio; Adverse effect; Number needed to treat; Internal medicine; Confidence interval; Relative risk; Anesthesia","authors":[{"name":"MDC Jiménez León","is_ca":false},{"name":"JA Hernandez Ramos","is_ca":false},{"name":"M Martín Rodríguez","is_ca":false},{"name":"E Guerrero Hurtado","is_ca":false},{"name":"A Prieto Romero","is_ca":false},{"name":"F Mayo Olveira","is_ca":false},{"name":"Francisco Martínez de la Torre","is_ca":false},{"name":"MD Canales Siguero","is_ca":false},{"name":"JM Ferrari Piquero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1080169857880549,"gpt":0.4437331214684653,"spread":0.3357161356804104,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001294575,0.0001993945,0.0004428156,0.0004071317,0.0001388628,0.00001920162,0.0001308025,0.000151892,0.00008673818],"category_scores_gemma":[0.001598883,0.0001373888,0.0002819662,0.001012902,0.0001402175,0.0004096697,0.00009255762,0.0007584765,0.00002033561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001743628,"about_ca_system_score_gemma":0.0003007832,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01848028,"about_ca_topic_score_gemma":0.0002291093,"domain_scores_codex":[0.9974421,0.0002761344,0.001248605,0.0003772755,0.000487853,0.0001679896],"domain_scores_gemma":[0.9965233,0.001807278,0.0006819681,0.0003625942,0.0003621849,0.0002627408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001220236,0.002031111,0.4467391,0.001526685,0.002199981,0.00000767636,0.01528658,0.002424326,0.4908717,0.0006180104,0.0004069241,0.03666767],"study_design_scores_gemma":[0.001217031,0.0004477126,0.9704087,0.001510419,0.0006746353,0.00002265205,0.002847759,0.0108897,0.01005577,0.0003788919,0.001389187,0.0001574734],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955447,0.0001120286,0.00004819948,0.0008224437,0.001032273,0.0006210504,0.00005541712,0.0001082755,0.001655659],"genre_scores_gemma":[0.9977956,0.001716991,0.00004621503,0.0001028224,0.0001975177,0.00001590141,0.00003314408,0.00002724741,0.00006459348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5236697,"threshold_uncertainty_score":0.9880558,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016926053","doi":"10.1136/ejhpharm-2020-eahpconf.280","title":"4CPS-179 The wide review of polypharmacy in the frail older person","year":2020,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; University Hospital Southampton NHS Foundation Trust","keywords":"Polypharmacy; Computer science; Older people; Gerontology; Medicine; Intensive care medicine","authors":[{"name":"Clare Kinahan","is_ca":false},{"name":"Helen Heery","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2952603473552379,"gpt":0.5051458419799638,"spread":0.2098854946247259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001971311,0.0002180692,0.0005360712,0.00003853687,0.0001113034,0.00002740901,0.0004537698,0.00006144589,0.001752],"category_scores_gemma":[0.0006069549,0.0001171876,0.0003866856,0.0006923288,0.0001198304,0.000319269,0.00007531911,0.001310545,0.0001223859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002003769,"about_ca_system_score_gemma":0.00008553724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002663054,"about_ca_topic_score_gemma":0.00001640647,"domain_scores_codex":[0.9968495,0.000874211,0.001013521,0.0003748448,0.0006083625,0.0002795678],"domain_scores_gemma":[0.9966597,0.002185593,0.0004582726,0.000322765,0.0001361023,0.0002375707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003257598,0.00174484,0.8786527,0.02570666,0.0005883718,0.00008796011,0.005878482,0.00002167945,0.0007741845,0.00008392327,0.04878496,0.03441868],"study_design_scores_gemma":[0.005064165,0.0003119827,0.08056637,0.001758266,0.0008336887,0.00002983914,0.00129448,0.005658835,0.0003564593,0.00002253782,0.9038954,0.0002079967],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.515739,0.03274159,0.00002772746,0.4392115,0.001650274,0.002278488,0.0000183749,0.0001001224,0.008232952],"genre_scores_gemma":[0.7027615,0.02209048,0.00002765037,0.2741812,0.0008253575,0.0000246061,0.00001617969,0.00001671941,0.00005625204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8551104,"threshold_uncertainty_score":0.9991605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360614867","doi":"10.1136/ejhpharm-2023-eahp.52","title":"4CPS-003 Experiences with a best possible medication history (BPMH) conducted by pharmacy students in the hospital setting: a scoping review","year":2023,"lang":"en","type":"review","venue":"Section 4: Clinical pharmacy services","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pharmacy; Patient safety; Medicine; Health care; Hospital pharmacy; MEDLINE; Clinical pharmacy; Family medicine; Medical education; Medical emergency","authors":[{"name":"Anita Elaine Weidmann","is_ca":false},{"name":"Julia Alexandra Schintler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3738245371887848,"gpt":0.5799558731640854,"spread":0.2061313359753005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00381418,0.0007551414,0.002482813,0.0002499488,0.0002093977,0.0001099764,0.00109279,0.0002233755,0.0008877848],"category_scores_gemma":[0.0005007033,0.0004652508,0.0006041612,0.001231091,0.0002952255,0.000737004,0.0002111757,0.002510396,0.0002886682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003583253,"about_ca_system_score_gemma":0.001063636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005044362,"about_ca_topic_score_gemma":0.00007347848,"domain_scores_codex":[0.9917675,0.001921638,0.00285211,0.001188491,0.001645684,0.0006246094],"domain_scores_gemma":[0.994136,0.00241946,0.002149948,0.0006446822,0.0001943645,0.0004555573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007341972,0.006949115,0.01642472,0.6530014,0.00238748,0.000431604,0.007208955,6.323439e-7,0.000002447141,0.000003530943,0.04365823,0.2691977],"study_design_scores_gemma":[0.002839939,0.0003741951,0.0000445362,0.1754513,0.003767895,0.00007666762,0.001452786,0.00006896379,9.331962e-7,0.000001230332,0.8154475,0.0004740499],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004150536,0.9817858,0.000002236383,0.002879683,0.0035605,0.006953109,0.00002936464,0.0002137434,0.0004250644],"genre_scores_gemma":[0.0006129916,0.9836544,0.00002587445,0.01198394,0.001026693,0.001587414,0.0005936899,0.000107486,0.0004074624],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7717893,"threshold_uncertainty_score":0.9997908,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016600733","doi":"10.1136/ejhpharm-2020-eahpconf.281","title":"4CPS-180 From evidence based medicine to practice: gum chewing for postoperative recovery of gastrointestinal function after colorectal surgery with interprofessional teamwork","year":2020,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Randomized controlled trial; Colorectal surgery; Teamwork; Defecation; Colostomy; Physical therapy; Surgery; Abdominal surgery","authors":[{"name":"Yn Lin","is_ca":false},{"name":"CL Chuan","is_ca":false},{"name":"CS Tsai","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0752212007927984,"gpt":0.3995477239843968,"spread":0.3243265231915984,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001497245,0.00034285,0.0009428312,0.0001701729,0.0001035985,0.00002782168,0.0001365741,0.0001059747,0.0007622387],"category_scores_gemma":[0.003815264,0.0002607619,0.0003059677,0.0006272187,0.0001241855,0.001035484,0.00008524799,0.0007201632,0.00003095816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00010465,"about_ca_system_score_gemma":0.0005667442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002773182,"about_ca_topic_score_gemma":0.00007595194,"domain_scores_codex":[0.9964452,0.0004946939,0.001317215,0.0008288324,0.0005760255,0.0003380184],"domain_scores_gemma":[0.9869624,0.0106692,0.0006748128,0.0002441818,0.0009612868,0.0004880713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3605815,0.0007456992,0.5520915,0.001141854,0.0005773719,0.000113587,0.000964969,0.0003694504,0.0617199,0.00000135601,0.006859902,0.01483293],"study_design_scores_gemma":[0.01430395,0.02417676,0.8051064,0.0468734,0.003063912,0.0002464361,0.00494598,0.01762212,0.04544895,0.0001048348,0.03654341,0.00156385],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422399,0.0003240939,0.0250652,0.02787353,0.00322078,0.00102386,0.00005868252,0.0001342154,0.0000597312],"genre_scores_gemma":[0.9470828,0.0000539669,0.01107108,0.03849693,0.002848092,0.0002032596,0.0001241537,0.00005500451,0.00006472494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3462775,"threshold_uncertainty_score":0.9999844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3137967144","doi":"10.1136/ejhpharm-2021-eahpconf.232","title":"4CPS-400 The role and value of a ward based pharmacist in the intensive care unit: the critical care physicians’ and nurses’ perceptions","year":2021,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Likert scale; Pharmacist; Intensive care unit; Medicine; Scale (ratio); Nursing; Clinical pharmacy; Critical care nursing; Family medicine; Pharmacy; Psychology; Health care; Intensive care medicine","authors":[{"name":"DL Rayner","is_ca":false},{"name":"Louise Grech","is_ca":false},{"name":"Anthony Serracino‐Inglott","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1463255160144417,"gpt":0.5062585645855626,"spread":0.359933048571121,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005230871,0.0001941059,0.0003421907,0.0000427898,0.0003342858,0.00007179518,0.0001908087,0.0000725205,0.0001342039],"category_scores_gemma":[0.0004393486,0.0001049817,0.0001790035,0.0003770579,0.0004944238,0.0002021237,0.0000995935,0.00107975,0.000007963194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002224784,"about_ca_system_score_gemma":0.0001045871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002701395,"about_ca_topic_score_gemma":0.0001774126,"domain_scores_codex":[0.9974174,0.001086535,0.0005323596,0.0003603452,0.0003625326,0.000240853],"domain_scores_gemma":[0.9954169,0.003202694,0.0001384962,0.0003175439,0.0008031737,0.0001212346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"qualitative","study_design_scores_codex":[0.001405144,0.0005042608,0.9237412,0.001240381,0.0001896849,0.00005364633,0.04289107,0.00008342234,0.001370728,0.0002475321,0.0001900141,0.02808296],"study_design_scores_gemma":[0.007136973,0.000411264,0.3532969,0.0003533619,0.001910663,0.0001289876,0.4480351,0.04501759,0.001443656,0.0002606983,0.1417105,0.0002943012],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9650415,0.00445719,0.00001301337,0.02760188,0.0009508033,0.0005802148,0.0000593389,0.00002678569,0.00126927],"genre_scores_gemma":[0.9643398,0.0008090467,0.00003308624,0.03422289,0.0004756048,0.00003516331,0.00004649881,0.00001715238,0.00002078818],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5704442,"threshold_uncertainty_score":0.4691035,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3138660907","doi":"10.1136/ejhpharm-2021-eahpconf.178","title":"4CPS-346 Evaluation of the implementation of ‘inhaler interviews’ during medication reconciliation in the pneumology service","year":2021,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Société de Pneumologie de Langue Française","keywords":"Inhaler; Checklist; Medicine; Pharmacy; Medical emergency; Physical therapy; Emergency medicine; Asthma; Nursing; Psychology; Internal medicine","authors":[{"name":"L Chebrek","is_ca":false},{"name":"Cecile Jonneaux","is_ca":false},{"name":"V Dehondt","is_ca":false},{"name":"P. Guillain","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1252837212849398,"gpt":0.4758899914348665,"spread":0.3506062701499267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003649776,0.0001090169,0.0002631092,0.0001002745,0.00008050336,0.000008849953,0.0001674437,0.00009754964,0.0008369952],"category_scores_gemma":[0.0001509352,0.00007243005,0.0001585341,0.0006914893,0.00005095538,0.0001897478,0.00005707023,0.0003243566,0.00001218292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008805776,"about_ca_system_score_gemma":0.0003702952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003458682,"about_ca_topic_score_gemma":0.002399969,"domain_scores_codex":[0.996056,0.001660266,0.001222091,0.0002594915,0.0006808931,0.0001212837],"domain_scores_gemma":[0.9974872,0.0002303267,0.0007242103,0.0003500242,0.001169831,0.0000383453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004975569,0.001376235,0.7762233,0.002499389,0.0003655463,0.000006102256,0.01609625,0.0008303928,0.1221601,0.0000902047,0.0004073627,0.07944752],"study_design_scores_gemma":[0.00546796,0.00007658787,0.9212652,0.0002176919,0.0004141951,0.00004060243,0.008058582,0.00647956,0.05514857,0.00009277443,0.00264307,0.00009521545],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896374,0.0002929969,0.000008743129,0.00749353,0.001327745,0.000636603,0.000007178493,0.00001414273,0.0005816892],"genre_scores_gemma":[0.9950498,0.0002209962,0.0000190243,0.004206244,0.0003531873,0.00004247856,0.00006928098,0.000009516028,0.00002952136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1450419,"threshold_uncertainty_score":0.9164511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2921353678","doi":"10.1136/ejhpharm-2019-eahpconf.269","title":"4CPS-120 Erlotinib in non-small-cell lung cancer without epidermal growth factor receptor activating mutations","year":2019,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Internal medicine; Epidermal growth factor receptor; Oncology; Lung cancer; Chemotherapy; Taxane; Erlotinib Hydrochloride; Adverse effect; Cancer; Breast cancer","authors":[{"name":"D Yáñez Feria","is_ca":false},{"name":"IM Carrión Madroñal","is_ca":false},{"name":"María Teresa Garrido Martínez","is_ca":false},{"name":"Olalla Montero Pérez","is_ca":false},{"name":"MD Santos Rubio","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03810566551067331,"gpt":0.4265117572884367,"spread":0.3884060917777634,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002788546,0.0002792147,0.0005138242,0.0001773294,0.0001465633,0.00005091207,0.0001386211,0.0001314009,0.001843556],"category_scores_gemma":[0.00004717434,0.0002435564,0.000202727,0.000475232,0.00003618236,0.0004555511,0.00005293433,0.0006335304,0.0001583315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002675132,"about_ca_system_score_gemma":0.000348595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004120447,"about_ca_topic_score_gemma":0.000682927,"domain_scores_codex":[0.9976998,0.0001473169,0.0008718575,0.0006155992,0.0002740781,0.0003913643],"domain_scores_gemma":[0.9984412,0.0003989588,0.0003895369,0.0002448043,0.0002607735,0.0002647936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003360832,0.0006065827,0.9859198,0.0006930245,0.0002709917,0.000005952942,0.0016713,0.0002087354,0.005227427,0.000004830262,0.000256299,0.004799022],"study_design_scores_gemma":[0.02112175,0.0003791597,0.9316035,0.0008339559,0.0006449881,0.00001134251,0.001699432,0.01729182,0.01074062,0.00003395948,0.01504033,0.0005991358],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895211,0.0002807151,0.00005820342,0.002047624,0.002669938,0.001614059,0.00006625272,0.0001437766,0.003598335],"genre_scores_gemma":[0.9931111,0.0003739614,0.0007857602,0.002366865,0.001064948,0.000223416,0.0001584076,0.00005948894,0.001856083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05431624,"threshold_uncertainty_score":0.9990689,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293230261","doi":"10.1136/ejhpharm-2022-eahp.128","title":"4CPS-097 Role of the pharmacist in the care of the lung transplant patient","year":2022,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Rio Tinto","keywords":"Medicine; Pharmacist; Lung transplantation; Bronchiectasis; Cystic fibrosis; Lung; Transplantation; Pulmonary function testing; Obstructive lung disease; Multidisciplinary team; Internal medicine; Physical therapy; Intensive care medicine; Pediatrics; COPD; Pharmacy; Family medicine; Nursing","authors":[{"name":"Ana Sangrador","is_ca":false},{"name":"V.M. Mora","is_ca":false},{"name":"Ruiz García. María","is_ca":false},{"name":"M Ramis","is_ca":false},{"name":"M Valero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04133134081204663,"gpt":0.408605612208214,"spread":0.3672742713961674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008122249,0.0001225395,0.0002758547,0.00004316902,0.0002164051,0.000006851537,0.0004063892,0.00003247565,0.0002082472],"category_scores_gemma":[0.00001429568,0.00006128438,0.0003449556,0.0004597928,0.00008204301,0.00005601961,0.0000577938,0.0006571315,8.69348e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003410988,"about_ca_system_score_gemma":0.00008534811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005856474,"about_ca_topic_score_gemma":0.0001873282,"domain_scores_codex":[0.9973603,0.001002811,0.0007485072,0.0002041057,0.0005381757,0.0001460974],"domain_scores_gemma":[0.9987733,0.0004889012,0.0003063901,0.0003137645,0.00007758141,0.00004001861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001023552,0.0003808333,0.966421,0.0005712005,0.0001016542,0.000005327334,0.01916397,0.0005169567,0.004640758,0.00005737444,0.00008824805,0.007029139],"study_design_scores_gemma":[0.005718448,0.0002294762,0.9111556,0.0001762361,0.0007461145,0.00007234581,0.01463783,0.002779028,0.01881294,0.0001070309,0.04541349,0.0001514908],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993878,0.00119875,0.000009041719,0.001604939,0.001732425,0.0006950892,0.0001468531,0.00001628161,0.0007186121],"genre_scores_gemma":[0.9961135,0.0002613344,0.00005386709,0.003297763,0.0001650488,0.00004635712,0.00002070007,0.00001209602,0.00002933109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05526542,"threshold_uncertainty_score":0.2854946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293230230","doi":"10.1136/ejhpharm-2022-eahp.129","title":"4CPS-099 Clinically relevant drug–drug interaction events in patients with abiraterone, enzalutamide or apalutamide treatment","year":2022,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Rio Tinto","keywords":"Enzalutamide; Medicine; Pharmacology; Prostate cancer; Drug interaction; Internal medicine; Drug; Cancer; Androgen receptor","authors":[{"name":"Julia Bodega-Azuara","is_ca":false},{"name":"Esther Vicente‐Escrig","is_ca":false},{"name":"T Cebolla-Beltrán","is_ca":false},{"name":"V Bosó-Ribelles","is_ca":false},{"name":"Josep Edo-Peñarrocha","is_ca":false},{"name":"M Fortanet-García","is_ca":false},{"name":"Raúl Ferrando‐Piqueres","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05257616929045679,"gpt":0.4169791532136755,"spread":0.3644029839232187,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001098145,0.0003758445,0.0006951922,0.0002978063,0.0003250771,0.00003212177,0.0002337258,0.00006266462,0.001318903],"category_scores_gemma":[0.00004895608,0.0002502095,0.0002411754,0.0006490801,0.00008042899,0.0003926481,0.0001898391,0.001026455,0.00009356408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001061009,"about_ca_system_score_gemma":0.0004057574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001645215,"about_ca_topic_score_gemma":0.0009855422,"domain_scores_codex":[0.9955091,0.0007806346,0.001410881,0.0008878315,0.0008623193,0.0005491721],"domain_scores_gemma":[0.9979852,0.0005315788,0.0004710204,0.0004318683,0.0002169005,0.0003634481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05060171,0.005350169,0.9268472,0.0001669254,0.0004319397,0.000100103,0.0008408386,0.0003078931,0.00007614766,8.677545e-7,0.0003701684,0.01490604],"study_design_scores_gemma":[0.05568903,0.007488136,0.8534317,0.0003251739,0.0004479021,0.00002958913,0.001443326,0.001841087,0.0005492133,0.00006431364,0.07819221,0.0004983183],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934112,0.0001711714,0.000002674199,0.002136442,0.001944979,0.001786523,0.00006265352,0.0001435047,0.0003408471],"genre_scores_gemma":[0.9914989,0.0009424459,0.0001139615,0.001683537,0.0005182568,0.0004224805,0.0004377475,0.0000674771,0.004315175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07782204,"threshold_uncertainty_score":0.999995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016962124","doi":"10.1136/ejhpharm-2020-eahpconf.198","title":"4CPS-097 Secondline treatment of metastatic non-small cell lung cancer with immune checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Rio Tinto","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Lung cancer; Nivolumab; Atezolizumab; Chemotherapy; Performance status; Retrospective cohort study; Cancer; Adverse effect; Immunotherapy","authors":[{"name":"FJ Salmeron Navas","is_ca":false},{"name":"C Martinez-Diaz","is_ca":false},{"name":"EM Barreiro-Fernandez","is_ca":false},{"name":"Mireia Cantero","is_ca":false},{"name":"S Fénix-Caballero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05666603131101178,"gpt":0.381958387943695,"spread":0.3252923566326832,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002813006,0.0003575243,0.0009278412,0.00007140022,0.00007991667,0.00002051219,0.0001024241,0.0000587026,0.00105206],"category_scores_gemma":[0.00001063942,0.0002412514,0.0004478262,0.0003742426,0.00007262454,0.0001198307,0.00004282055,0.0002638317,0.00002664664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001044574,"about_ca_system_score_gemma":0.000244976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002288447,"about_ca_topic_score_gemma":0.0002898037,"domain_scores_codex":[0.9975357,0.0001463442,0.001173563,0.0005636647,0.0002829455,0.000297794],"domain_scores_gemma":[0.9983329,0.0001838023,0.000565421,0.000294303,0.0001936082,0.0004299653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02402975,0.01971618,0.7800916,0.01385671,0.01367997,0.0009241948,0.009053528,0.003525547,0.05762848,0.00001231372,0.001242792,0.07623888],"study_design_scores_gemma":[0.1229744,0.02671317,0.1022988,0.001278016,0.01887833,0.0001272028,0.003830937,0.05613391,0.5416508,0.00003150884,0.1245206,0.00156226],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897315,0.004012099,0.0001356273,0.003716846,0.0006488616,0.001201165,0.00009726449,0.00008515687,0.0003715005],"genre_scores_gemma":[0.992585,0.002086117,0.001830224,0.001939553,0.0009953633,0.0001200701,0.0001368308,0.00005387227,0.0002529679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6777928,"threshold_uncertainty_score":0.9998611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945528492","doi":"10.1136/ejhpharm-2019-eahpconf.404","title":"4CPS-255 The effect of an enhancing medication adherence programme for a type 2 diabetes mellitus network","year":2019,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Chulabhorn Research Institute; Copperbelt University; Kidney Foundation of Canada","keywords":"Medicine; Pharmacist; Pharmacy; Test (biology); Family medicine; Type 2 Diabetes Mellitus; Diabetes mellitus","authors":[{"name":"T Pholchai","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07543680084374962,"gpt":0.4363149610199399,"spread":0.3608781601761902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002362029,0.000156424,0.0004160091,0.0000314278,0.00009730212,0.00002113646,0.0002758589,0.00009770059,0.0007028799],"category_scores_gemma":[0.0002171181,0.0001009956,0.0001459057,0.0003669083,0.00008800684,0.0001748291,0.00003369981,0.000319417,0.0002646608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002037753,"about_ca_system_score_gemma":0.0001143923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007439697,"about_ca_topic_score_gemma":0.0000330345,"domain_scores_codex":[0.9979721,0.0002844031,0.0007186617,0.0003839869,0.0003339272,0.0003068997],"domain_scores_gemma":[0.9977057,0.000903169,0.0004701508,0.00045509,0.0002616034,0.0002043013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00313829,0.0004918036,0.6077268,0.003720975,0.000439551,0.000001069519,0.0003592706,0.0001164503,0.01391646,0.00009611628,0.003005158,0.3669881],"study_design_scores_gemma":[0.02248877,0.02388682,0.1832634,0.003061973,0.001752033,0.000021371,0.0009476162,0.1642094,0.07258232,0.00161961,0.5252533,0.0009133582],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992766,0.001006357,0.0001668942,0.001090027,0.002670803,0.001789076,0.000002470141,0.00009801414,0.0004103633],"genre_scores_gemma":[0.9949805,0.0003098586,0.0005029169,0.002039123,0.001512465,0.000208262,0.00008687472,0.00001913404,0.0003408617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5222481,"threshold_uncertainty_score":0.7696041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393005622","doi":"10.1136/ejhpharm-2024-eahp.183","title":"4CPS-079 Indirect comparison of il-13 inhibitors plus topical corticosteroids in moderate to severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Dupilumab; Placebo; Corticosteroid; Internal medicine; Clinical endpoint; Gastroenterology; Randomized controlled trial; Dermatology","authors":[{"name":"FJ Salmerón-Navas","is_ca":false},{"name":"M Domínguez-Cantero","is_ca":false},{"name":"MA Blanco-Castaño","is_ca":false},{"name":"J Diaz-Navarro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05583459261996076,"gpt":0.4134032319752196,"spread":0.3575686393552588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002299755,0.0001900256,0.00068429,0.0002150118,0.00005714939,0.00004213545,0.0001273327,0.0001670583,0.0003525059],"category_scores_gemma":[0.000075128,0.0001712554,0.0001912968,0.0004285313,0.00007233765,0.0002294679,0.00008914666,0.0005750317,0.0001280733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005402495,"about_ca_system_score_gemma":0.0001510234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002119955,"about_ca_topic_score_gemma":0.0004937087,"domain_scores_codex":[0.997718,0.0002282169,0.001124296,0.0004099816,0.0002612231,0.0002582461],"domain_scores_gemma":[0.9989541,0.000363755,0.0001114369,0.0002102772,0.00008775188,0.000272723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006100775,0.0005065156,0.9714418,0.001553247,0.0001870417,0.0001908314,0.001366907,0.0003210188,0.0001772184,0.00001738572,0.007140511,0.01648745],"study_design_scores_gemma":[0.004626037,0.0003032766,0.8835452,0.001187781,0.000331727,0.0001691445,0.000505107,0.0468471,0.006158151,0.0003530195,0.05562275,0.0003506649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905388,0.001543362,0.0000480087,0.003308867,0.002673251,0.0004367956,0.00002282812,0.000159266,0.001268865],"genre_scores_gemma":[0.9952396,0.0001570052,0.00007584658,0.003692996,0.0005150572,0.00003309639,0.00004311485,0.00002052489,0.0002227212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08789656,"threshold_uncertainty_score":0.6983591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}